DekaBank Deutsche Girozentrale
RLAY icon

DekaBank Deutsche Girozentrale’s Relay Therapeutics RLAY Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$579K Hold
60,000
– – ﹤0.01% 861
2026
Q1 		$591K Hold
60,000
– – ﹤0.01% 861
2025
Q4 		$532K Hold
60,000
– – ﹤0.01% 988
2025
Q3 		$527K Hold
60,000
– – ﹤0.01% 979
2025
Q2 		$531K Sell
60,000
-8,937
-13% -$26.6K ﹤0.01% 972
2025
Q1 		$572K Buy
68,937
+8,937
+15% +$35K ﹤0.01% 950
2024
Q4 		$464K Hold
60,000
– – ﹤0.01% 1018
2024
Q3 		$490K Hold
60,000
– – ﹤0.01% 1018
2024
Q2 		$490K Sell
60,000
-8,937
-13% -$61.1K ﹤0.01% 1010
2024
Q1 		$571K Hold
68,937
– – ﹤0.01% 979
2023
Q4 		$763K Buy
68,937
+8,937
+15% +$75.4K ﹤0.01% 956
2023
Q3 		$494K Hold
60,000
– – ﹤0.01% 1019
2023
Q2 		$768K Hold
60,000
– – ﹤0.01% 931
2023
Q1 		$955K Buy
60,000
+29,900
+99% +$536K ﹤0.01% 875
2022
Q4 		$445K Hold
30,100
– – ﹤0.01% 1061
2022
Q3 		$704K Hold
30,100
– – ﹤0.01% 971
2022
Q2 		$505K Hold
30,100
– – ﹤0.01% 1018
2022
Q1 		$923K Sell
30,100
-300
-1% -$7.28K ﹤0.01% 922
2021
Q4 		$918K Buy
30,400
+700
+2% +$22.1K ﹤0.01% 948
2021
Q3 		$992K Hold
29,700
– – ﹤0.01% 901
2021
Q2 		$1.11M Hold
29,700
– – ﹤0.01% 883
2021
Q1 		$1.06M Buy
29,700
+3,000
+11% +$130K ﹤0.01% 889
2020
Q4 		$1.13M Buy
+26,700
New +$1.21M ﹤0.01% 834

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

DekaBank Deutsche Girozentrale's RLAY Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Relay Therapeutics (RLAY) position steady in Q2 2026 at 60,000 shares worth $579K. The position accounts for ﹤0.01% of the portfolio, ranked #861.

DekaBank Deutsche Girozentrale first reported a position in RLAY in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.13M in Q4 2020. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • DekaBank Deutsche Girozentrale held 60,000 shares of Relay Therapeutics worth $579K as of Q2 2026.
  • DekaBank Deutsche Girozentrale left its Relay Therapeutics share count unchanged in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #861 holding.
  • DekaBank Deutsche Girozentrale first reported a position in Relay Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • DekaBank Deutsche Girozentrale's Relay Therapeutics position peaked at $1.13M in Q4 2020.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.